Patents by Inventor Rishab K. Gupta

Rishab K. Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED DELIVERY OF DRUGS TO THE BRAIN
    Publication number: 20210269513
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 2, 2021
    Inventors: Mark C. Glassy, Rishab K Gupta
  • Enhanced delivery of drugs to the brain
    Patent number: 11028155
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: June 8, 2021
    Assignee: Nascent Biotech, Inc.
    Inventors: Mark C. Glassy, Rishab K. Gupta
  • ENHANCED DELIVERY OF DRUGS TO THE BRAIN
    Publication number: 20170073400
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Application
    Filed: September 9, 2016
    Publication date: March 16, 2017
    Inventors: Mark C. Glassy, Rishab K. Gupta
  • 35 kD tumor associated protein antigen: uses and methods of detection
    Patent number: 7097846
    Abstract: This invention provides the isolation and characterization of a tumor associated antigen which can be used for immunodiagnosis, immunoprognosis, and therapy of human cancer. The antigen is a protein molecule with a molecular weight of about 35 kD after reduction and separation by SDS-polyacrylamide gel electrophoresis. The antigen has been detected in serum of cancer patients.
    Type: Grant
    Filed: October 30, 2002
    Date of Patent: August 29, 2006
    Assignee: CancerVax Corporation
    Inventors: Jan H. Wong, Rishab K. Gupta, Donald L. Morton
  • 35 kappaD tumor associated protein antigen: uses and methods detection
    Publication number: 20030064065
    Abstract: This invention provides the isolation and characterization of a tumor associated antigen which can be used for immunodiagnosis, immunoprognosis, and therapy of human cancer. The antigen is a protein molecule with a molecular weight of about 35 kD after reduction and separation by SDS-polyacrylamide gel electrophoresis. The antigen has been detected in serum of cancer patients.
    Type: Application
    Filed: October 30, 2002
    Publication date: April 3, 2003
    Inventors: Jan H. Wong, Rishab K. Gupta, Donald L. Morton
  • Method of detection of urinary tumor associated antigen
    Patent number: 5700649
    Abstract: The present invention describes Urinary Tumor Associated Antigen (UTAA), its isolation and use in diagnostic assays. In particular, UTAA has been identified in samples from cancer patients, in some cases as part of an immune complex of UTAA and UTAA-specific immunoglobulin. Isolated UTAA also may be formulated as a pharmaceutical for production of antibodies or as a vaccine.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: December 23, 1997
    Inventors: Donald L. Morton, Rishab K. Gupta, David M. Euhus